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Abstract
Vitamin D is a secosteroid hormone
that has expanding importance for a
healthy lifestyle and disease prevention. A
multitude of studies have highlighted that
vitamin D acts not only in bone and
calcium homeostasis but is critically
important for human immunity. The
discovery that the storage form of vitamin
D (25-hydroxyvitamin D3) can be locally
converted to the active form
(1,25-hydroxyvitamin D3) in immune cells,
epithelial cells and numerous other
non-renal tissues highlights the importance
of maintaining sufficient stores. When
responding to a specific external stimulus,
like bacterial invasion, intracrine synthesis
of active vitamin D has the ability to
regulate gene expression providing a
specific response and directing cellular
actions. These responses include the
generation of antimicrobial peptides with
production of these peptides dependent on
vitamin D status. Vitamin D deficiency is
associated with an increased rate of
infection. This paper highlights the
antibiotic like actions of vitamin D and
importance of vitamin D sufficiency.

Introduction
Vitamin D can be obtained
through diet in the form of D2
(ergocalciferol, plant form) or D3
(cholecalciferol, animal form) with
D3 more efficiently converted to the
storage form 25-hydroxyvitamin
D3 or 25(OH)D. Unfortunately, diet
provides very little of this necessary
nutrient with approximately 80-90%
of vitamin D3 made endogenously
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in the epidermis after exposure to
the UVB rays in sunlight.1 Due to
West Virginia’s location, from midOctober to mid-March negligible
vitamin D is produced through
cutaneous synthesis due to the
decrease in atmosphere penetration
of UVB rays. Whether cutaneously
produced or injected, vitamin D3 is
bound to Vitamin D Binding Protein
(VDBP) and circulated throughout
the body.2 Once vitamin D3 reaches
the liver, hydroxylation by CYP27A1
occurs to form 25(OH)D which
is the major circulating form and
best indicator of vitamin D status.
Sufficiency is defined as > 30ng/
ml.1,2,4 A second enzyme, CYP27B1,
is found in over 30 cell types and
acts to further metabolize 25(OH)
D to form the locally produced
intracrine 1,25(OH)2D3 which is
the active form of vitamin D.1,3,4
Unlike the intracrine mechanism,
the endocrine mechanism of vitamin
D activation is in the proximal
convoluted tubules of the kidneys
where CYP27B1 is directly regulated
by calcium and indirectly by PTH,
linking vitamin D to a role in calcium
homeostasis. Since its discovery,
local production of active vitamin
D has been shown to be important
for optimal cellular functioning.

Vitamin D, Immunity and
Toll-like Receptors
Active vitamin D has been shown
to play a direct role in regulating
transcription of approximately
3% of the human genome in over
30 different tissue types through
vitamin D response elements (VDRE)
on genes.2,5 Among its effects,
vitamin D3 has been found to be an
immune regulator with the ability
to stimulate antimicrobial defense
in epithelial barriers.6 Of note,

antimicrobial actions of sunlight
and vitamin D are not new concepts.
In 1903, Dr. Niels Ryberg Finsen
won the Nobel Prize for his work
on the use of concentrated photo
irradiation to cure lupus vulgaris,
a cutaneous form of tuberculosis.7
Vitamin D’s role in innate
immunity begins with toll-like
receptors (TLRs). Found on many
white blood cells, the ability
of these receptors to recognize
certain pathogen associated
molecular patterns (PAMPs)
such as lipopolysaccharides and
flagella allows the body to respond
to pathogens regardless of prior
exposure. In the case of invading
organisms such as M. tuberculosis,
the TLR1 and TLR2 receptors
on macrophages and monocytes
recognize the bacterium and
form a heterodimer. In addition
to stimulating phagocytosis, the
heterodimer induces the expression
of CYP27B1 and vitamin D receptor
(VDR). The resulting increase in local
1,25(OH)2D3 and VDR expression
creates an intracrine system that
increases the oxidative burst
potential of monocytes, recruits
other immune cells to fight infection,
and induces formation of natural
antimicrobial peptides – most notably
cathelicidins and human defensins.8

Vitamin D and Antimicrobial
Peptide Production
Protection against assault from
microbial pathogens involves a
complex series of skin, mucosal
surface and immune cell interactions
that produce antimicrobial peptides
and proteins in response to specific
stimuli (see Figure 1, PAMP). In
macrophages and monocytes,
antimicrobial peptide production
by the vitamin D intracrine
system is best demonstrated by
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neutralizing the fever-producing
endotoxin of gram negative bacteria.8
By stimulating chemokine and
cytokine production, LL37 can
recruit other cells to participate in
immune responses.10 Intracellularly,
CAMP is able to stimulate autophagy
which allows macrophages and
monocytes to destroy intracellular
organelles, proteins, or phagocytosed
bacteria.11 This is particularly
important when one considers M.
tuberculosis persists in macrophages
by preventing autophagy.7
In addition to CAMP, 6
α-defensins and 4 β-defensins with
anti-microbial properties are also
induced by the 1,25(OH)D intracrine
system.8 These peptides can act
synergistically with cathelicidin
to disrupt microbial membranes
and stimulate autophagy.11

Vitamin D, Immunity and
Epithelial Barriers

the production of hCAP18, a
cathelicidin antimicrobial peptide
(CAMP) precusor that is cleaved
to release LL37 (Figure 2).
LL37 has many protective
mechanisms. A largely cationic

peptide, it can act as an antibiotic
by disrupting the membranes of
microbes through its interaction with
their negatively charged capsular
polysaccharides.10 It also protects
against symptoms of infection by

Similar to macrophages and
monocytes, vitamin D is closely
tied to the immunological function
of epithelial barriers such as the
respiratory epithelium, skin,
and placenta.10 In addition to
strengthening the connections
between the epithelial cells, vitamin
D can stimulate the formation of
antimicrobial peptides similar to
those seen in macrophages and
monocytes.8 In the lungs, normal
human bronchial epithelial cells
can be induced by 1,25(OH)D to
produce CAMP. This is especially
significant when considering
populations who frequently
experience respiratory infections.
Cystic fibrosis patients, for example,
may benefit from vitamin D-induced
CAMP production to help combat
infection by Pseudomonas aeruginosa.10
Epithelial keratinocytes of
damaged skin are also strong
producers of CAMP. Factors
released from injured cells promote
the formation of CYP27B1, leading
to a local increase in 1,25(OH)D.
This rise in active vitamin D levels
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increases the keratinocyte expression
of TLR2 and TLR4 which prepares
the epithelium to react to potential
pathogens.12 If TLR2 is activated,
CAMP is produced by a mechanism
similar to that of macrophages and
monocytes and, LL37 stimulates
keratinocyte migration and repair
of damaged epithelium.10
Decidual and trophoblastic cells
of the placenta constitutively express
CYP27B1 to maintain a high level
of 1,25(OH)D and therefore a high
level of CAMP. This antibacterial
environment could enhance the
placenta’s function as a barrier to
preempt fetal infection from microbes
such as Listeria monocytogenes
and Group B Streptococcus .12

Vitamin D Stores and
Seasonal Immunity
Vitamin D may also contribute
to the seasonality of infections.
Influenza epidemics for example,
long noted to occur during the
winter months, were historically
attributed to increased transference
from populations collecting indoors
to avoid the cold.13 However, this
hypothesis could not explain a
1977 study in which individuals
given a live attenuated influenza
vaccine in the winter were 8x more
likely to display signs of infection
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than when given the same vaccine
in the summer.14 In years since,
extensive work has detailed the
global absence of influenza epidemics
during months with the greatest
sunlight intensity.15 This has helped
implicate sunlight and corresponding
vitamin D levels as a contributor of
influenza’s seasonality. As expected,
vitamin D levels have been shown
to be lowest during peak times of
infection, and it is hypothesized
that the decreased vitamin D
levels lead to lower antimicrobial
peptide and protein levels reducing
one’s ability to combat infection.16
Similarly, lower vitamin D levels
could explain why individuals are
more susceptible to live attenuated
virus vaccines in the winter.
Like influenza, studies have
also linked septicemia with UVB
activated vitamin D. William Grant
of the Sunlight, Nutrition and
Health Research Center found that
septicemia rates were highest in
the winter and in the northeastern
US, and were lowest in the summer
and in the southwestern US –
corresponding to the areas of low
and high UVB levels respectively.
Further supporting his conclusions,
African Americans, who have
decreased ability to activate vitamin
D in the presence of UVB, were
more likely than white Americans

to get septicemia.17 More recent
studies have elaborated on this
connection by finding a high
prevalence of decreased vitamin D
binding protein levels in addition
to vitamin D deficiency in patients
with sepsis.18 Randomized controlled
clinical trials are currently in
progress to establish the effect
of vitamin D supplementation
on ICU septic patients.
Several studies have investigated
vitamin D supplementation’s ability
to prevent infection. One double
blind trial of 208 women showed that
no individuals reported an upper
respiratory infection (URI)/influenza
infection during the winter after
receiving supplementation of 2,000
IU of vitamin D daily for a year; <5%
reported URI/influenza during the
winter after taking 800 IU, and >20%
reported URI/Influenza during the
winter when given the placebo.19
In a much more extensive study, a
survey of 18,883 individuals 12 years
and older showed that those with
serum 25(OH)D levels of ≤10 ng/mL
had 55% increased risk of having a
recent URI compared to those with a
serum 25(OH)D level of ≥30 ng/mL.20
In addition to preventing influenza,
vitamin D therapy has been
shown to modulate disseminated
intravascular coagulation and
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inflammatory cytokines in
animal models of sepsis.18

Vitamin D Sufficiency
The most plentiful and stable
metabolite of vitamin D is
25-hydroxyvitamin D and it is used
as the primary indicator of vitamin
D sufficiency (defined as 25(OH)
D > 30ng/mL).21,22,23 Safety research
by the Mayo Clinic supports an
upper limit of up to 10,000 IU of
vitamin D3 daily with the National
Academy of Sciences recommending
an upper intake level of 4,000
IU per day.22 Supplementation
protocols for insufficiency are
highlighted in reference 23.
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Summary
Local production of active vitamin
D is critical for human immunity.
The apparent link between vitamin
D stores and immunity comes
from the ability of active vitamin
D to induce several components
of the innate immune system such
as cathelicidin, defensins, and
other genes that control oxidative
burst potency. This link has been
strengthened by discovering
TLRs’ role in locally increasing
active vitamin D levels to create an
intracrine system. It is becoming
apparent that vitamin D sufficiency
is important in many facets of
optimal human health and immunity
including the impact of seasonal
changes on communicable diseases.
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